During the past decade, Joseph C Gathe conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Joseph C Gathe" #1 sponsor was "Glaxo Wellcome" with 4 trials, followed by "Bristol-Myers Squibb" with 3 trials sponsored, "Abbott" with 2 trials sponsored, "Agouron Pharmaceuticals" with 1 trials sponsored and "Chiron Corporation" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

According to Clinical.Site data, the most researched conditions in "Joseph C Gathe" are "HIV Infections" (16 trials), "Diarrhea" (1 trials), "Lipodystrophy" (1 trials), "Pneumonia, Pneumocystis Carinii" (1 trials) and "Toxoplasmosis, Cerebral" (1 trials). Many other conditions were trialed in "Joseph C Gathe" in a lesser frequency.

Most popular intervention types in "Joseph C Gathe" are "Drug" (16 trials). Other intervention types were less common.

The name of intervention was led by "Nelfinavir mesylate" (6 trials), "Lamivudine" (4 trials), "Ritonavir" (4 trials), "Lamivudine/Zidovudine" (3 trials) and "Lopinavir/Ritonavir" (3 trials). Other intervention names were less common.

The vast majority of trials in "Joseph C Gathe" are 16 trials for "All" genders.

Currently, there are NaN active trials in "Joseph C Gathe". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Joseph C Gathe, 1 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Joseph C Gathe, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".